ArticlePloS one2025
Foliar application of fullerenol and zinc oxide nanoparticles improves stress resilience in drought-sensitive Arabidopsis thaliana.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Use of Fullerenol as a Seed Treatment to Maintain the Intensity of Physiological and Biochemical Processes of Wheat in Control and Low-Temperature Conditions.Plants (Basel, Switzerland) · 2026Article
- Physiological and Metabolic Changes Induced by Fullerene CPlants (Basel, Switzerland) · 2026Article
- Eco-Physiological and Molecular Roles of Zinc Oxide Nanoparticles (ZnO-NPs) in Mitigating Abiotic Stress: A Comprehensive Review.Plants (Basel, Switzerland) · 2026Review
- The Balkan Region and the "Nano Gap": An Underexplored Dimension of In Vitro Biotechnology for Woody Plants.Plants (Basel, Switzerland) · 2025Review
- Short- and Long-Term Effects of Ca(OH)Materials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to characterise the chemical properties of fullerenol nanoparticles (FNP) and zinc oxide nanoparticles (ZnO nano), as well as their physiological and molecular effects following foliar application on Arabidopsis thaliana. Additionally, we explored the potential synergistic impact of combining ZnO nano with FNPs to enhance plant resilience under drought stress conditions. Chemical characterisation confirmed the successful formation of a stable FNP-ZnO aggregate. The previously established biostimulatory effects of fullerenol at micromolar concentrations were reaffirmed, highlighting its unique chemical properties. We demonstrated that a low dose (10 mg/L) of ZnO nano, used as a foliar application for the first time in Arabidopsis thaliana, positively influenced drought stress acclimatization. Our findings indicate that FNP and ZnO alleviate oxidative stress by mitigating the impact of reactive oxygen species (ROS), modulating antioxidant enzyme activities, and stabilising redox balance. Photosynthetic performance, stomatal conductance and water-use efficiency were optimized, particularly through fullerenol application, due to its unique antioxidative and hygroscopic properties. We further analyzed the expression of selected drought-response genes involved in ABA-dependent and ABA-independent water deficit acclimation in Col-0 wild-type and pp2ca-1 drought hypersensitive mutant backgrounds. Our results revealed distinct gene expression changes in response to nanoparticle treatments, demonstrating modulation of ABA signaling and stress-related transcription factors. The combined application of FNP and ZnO exhibited unique, synergistic protective effects in drought acclimation. Future research will further elucidate the direct mechanisms linking these physiological outcomes to specific nanoparticle properties, paving the way for innovative strategies in sustainable agriculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.